Cervical spondylosis is a common cause of neck pain and stiffness arising due to wear and tear of the protective discs between the vertebrae in the neck. The condition can lead to compression of nerves in the neck and radiating pain, numbness or weakness in the arms. Cervical spondylosis treatment involves the use of medications, physical therapy, epidural injections or surgical intervention to relieve pain and improve mobility. The global cervical spondylosis treatment market is estimated to be valued at US$ 6.65 Mn in 2024 and is expected to exhibit a CAGR of 3.5% over the forecast period 2024 to 2030.
The cervical spondylosis treatment market is driven by factors such as the rising geriatric population worldwide which are more prone to develop cervical spondylosis due to natural age-related degeneration of the cervical discs and joints. Moreover, sedentary lifestyles and prolonged device usage like smartphones have further increased the risk of cervical issues. Several innovative drugs and therapies are being developed to provide minimally invasive and long-lasting relief from cervical spondylosis symptoms.
Key Takeaways
Key players operating in the cervical spondylosis treatment market include American Tower Corporation, AT&T Inc., Bharti Infratel Limited, China Tower Corporation, Crown Castle International Corporation, GTL Infrastructure Ltd, Helios Tower Africa, SBA Communications Corporation, T-Mobile Tower, and Viom Networks. These players are focused on developing advanced cervical collar devices and cervical fusion surgery techniques.
The rising awareness regarding early diagnosis and treatment of cervical spondylosis presents significant growth opportunities for players. Moreover, increasing medicare reimbursements for cervical treatments in major markets like the US and Europe is supporting the adoption of advanced intervention procedures.
Globally, Asia Pacific is expected to witness high expansion in the cervical spondylosis treatment market during the forecast period. This can be attributed to rapidly developing healthcare infrastructure and rising medical tourism in countries like India, China and South Korea.
Market Drivers and Restrains
The key driver for cervical spondylosis treatment market is increasing aging population globally. It is estimated that by 2050, one in six people in the world will be over age 65. Cervical issues are more common in the geriatric group. Moreover, non-adoption of proper ergonomics at workplaces and use of smartphones for prolonged hours is aggravating the risk of cervical problems in younger population as well.
The key restraint for the market is high cost of surgical treatments for cervical spondylosis. Cervical fusion surgeries require long hospital stay and rehabilitation. This makes such procedures unaffordable for many in developing regions. Moreover, lack of awareness regarding early symptoms in rural areas also limits full market potential.
Segment Analysis
Medication is the dominating sub segment in the Cervical Spondylosis Treatment Market. Medication includes nonsteroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, opioids (narcotics), corticosteroid injections, and others. NSAIDs such as naproxen and ibuprofen are often prescribed to relieve neck pain and inflammation associated with cervical spondylosis. They are the most common and affordable treatment option available.
Global Analysis
North America is expected to hold the largest share in the cervical spondylosis treatment market size during the forecast period. Factors such as the rising geriatric population, increasing prevalence of neck pain and other cervical disorders, advanced healthcare facilities, and availability of technologically advanced cervical treatment procedures in the region are anticipated to drive market growth. The Asia Pacific region is projected to experience the fastest growth with a CAGR of 4.8% during the forecast period. Rapidly developing economies, rising awareness about cervical disorders and treatments, growing medical tourism industry, and improving healthcare infrastructure in emerging Asian countries are key factors fueling the APAC market.
Get more insights on: Cervical Spondylosis Treatment Market
